(Q28480387)

English

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking (English)

0 references

0 references

0 references

Alexandros Makriyannis

3

0 references

Bernard Le Foll

5

0 references

author name string

Islam Gamaleddin

1

0 references

Alexander Zvonok

2

0 references

Steven R Goldberg

4

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

1

0 references

e29900

0 references

copyright license

Creative Commons CC0 License

26 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

19 March 2017

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

19 March 2017

CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

19 March 2017

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

19 March 2017

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

19 March 2017

Role of endogenous cannabinoids in synaptic signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

19 March 2017

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

7 April 2017

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Brain cannabinoid CB2 receptor in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Treatment of tobacco dependence: integrating recent progress into practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

CB1 receptor antagonists for the treatment of nicotine addiction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

The endocannabinoid system and its therapeutic exploitation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

The endocannabinoid system: a general view and latest additions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

The cannabinoid system and immune modulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

Inhibition of pain responses by activation of CB(2) cannabinoid receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

29 September 2017

CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

2 June 2018

Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

2 June 2018

Heroin self-administration in rats under a progressive ratio schedule of reinforcement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

2 June 2018

Nicotine maintains robust self-administration in rats on a limited-access schedule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

2 June 2018

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0029900

21 January 2018

Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3266883

27 November 2018

Identifiers

10.1371/JOURNAL.PONE.0029900

0 references

2012PLoSO...729900G

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28480387&oldid=1868310008"